Evaluating Peptide Purity: CoAs, HPLC & What the Data Tells You

September 26, 2026 · By My Store 3 Admin

When sourcing peptides for research, purity and identity documentation are not administrative formalities — they are methodologically significant. The quality of a research compound directly affects the reliability and interpretability of experimental data. This article explains the key analytical methods used to assess peptide purity, how to read the resulting documentation, and what researchers should look for when evaluating a supplier’s quality standards.

Why Purity Matters in Peptide Research

A peptide sample that contains impurities — whether related substances, residual solvents, degradation products, or incorrectly synthesised sequences — can produce confounded results in downstream assays. If an observed biological effect is attributed to the target compound but is partially or wholly caused by an impurity, the experimental conclusion is compromised.

This is particularly relevant for research into compounds like BPC-157, where the biological effects under investigation are subtle and context-dependent. Researchers comparing findings across studies should consider whether differences in source purity could account for variation in results.

HPLC: High-Performance Liquid Chromatography

HPLC is the standard analytical method for assessing peptide purity. It works by passing a dissolved sample through a column under high pressure; different components of the sample travel through the column at different rates and are detected as they elute, producing a chromatogram.

Key terms to understand when reviewing HPLC data:

Peak area percentage — the proportion of the total detected signal attributable to the target compound. A purity of ≥98% means the target peptide accounts for at least 98% of the detected area, with no more than 2% attributable to other species.
Retention time — the time taken for the target compound to elute from the column. Consistent retention times across batches indicate a consistent compound.
Baseline resolution — the degree to which peaks are separated. Well-resolved peaks indicate a clean sample; overlapping peaks may indicate co-eluting impurities.

HPLC purity is typically reported as a percentage. For research-grade peptides, ≥98% purity by HPLC is the accepted minimum standard. Bloom Vitality supplies peptides meeting this threshold, with batch-specific HPLC data available via our Certificates & Documentation page.

Mass Spectrometry for Identity Confirmation

HPLC measures purity but does not confirm molecular identity. Mass spectrometry (MS) — typically electrospray ionisation MS (ESI-MS) or MALDI-TOF — is used to confirm that the compound’s molecular weight matches the theoretical mass of the target peptide sequence.

A Certificate of Analysis that includes both HPLC purity and MS identity confirmation provides stronger analytical assurance than HPLC alone. Researchers should look for both data types when evaluating supplier documentation.

How to Read a Certificate of Analysis

A Certificate of Analysis (CoA) is a document produced by an analytical laboratory that records the results of testing performed on a specific batch of a compound. Key fields to review:

Product name and CAS number — confirms the compound is correctly identified
Batch or lot number — links the CoA to a specific production batch; allows traceability
Testing date — indicates how recently the batch was analysed; older CoAs may not reflect current batch condition
HPLC purity (%) — the primary purity metric; should be ≥98% for research-grade material
Molecular weight (observed vs theoretical) — from MS data; should match within acceptable instrument tolerance
Appearance — typically described as a white to off-white lyophilised powder
Testing laboratory — ideally an independent third-party laboratory, not the manufacturer’s in-house facility

For a comprehensive field-by-field guide to CoA documents, including how to verify batch correspondence and assess laboratory independence, see: Peptide Certificate of Analysis: How to Read, Verify and Interpret CoA Documentation.

Third-Party vs In-House Testing

An important distinction when evaluating supplier documentation is whether testing was conducted by an independent third-party laboratory or in-house by the manufacturer. Third-party testing provides a greater degree of assurance because it eliminates the potential for conflict of interest in the analytical process.

All Bloom Vitality peptides are tested by independent third-party laboratories. CoAs are batch-specific, meaning each production batch has its own analytical record rather than a generic document applied across multiple batches.

Accessing Bloom Vitality CoA Documentation

Batch-specific Certificates of Analysis for all Bloom Vitality research compounds — including BPC-157 and TB-500 — are available via our Certificates & Documentation page. Our testing methodology and quality standards are described in full on the Testing & Quality page.

This article is written for informational and research purposes only. All Bloom Vitality products are supplied for in vitro laboratory and research use only. Nothing in this article constitutes medical advice.